The Medicines and Healthcare products Regulatory Agency’s (MHRA) has issued a class 2 recall for clarithromycin 500 mg powder, manufactured by Hameln Pharma Ltd, for poor quality raw materials.
Hameln Pharma is recalling some batches of Clarithromycin 500 mg powder following an inspection of the clarithromycin lactobionate raw material manufacturer.
The certification of suitability for use in medicines was withdrawn due to non-compliance with good manufacturing practice.
The recall is being undertaken as a precautionary measure.
Healthcare professionals should stop supplying the affected batches, quarantine the remaining stock, and return it to the supplier.
Patients need not take any action as this product is administered by healthcare professionals in a hospital or healthcare setting.
Those who experience any adverse reactions should seek medical attention.
